Little Silver, NJ, based Investment company Wbi Investments (Current Portfolio) buys AbbVie Inc, Raymond James Financial Inc, Best Buy Co Inc, Diamondback Energy Inc, Cummins Inc, sells AstraZeneca PLC, Novavax Inc, Pfizer Inc, Bank of America Corp, Coca-Cola Europacific Partners PLC during the 3-months ended 2021Q1, according to the most recent filings of the investment company, Wbi Investments. As of 2021Q1, Wbi Investments owns 159 stocks with a total value of $471 million. These are the details of the buys and sells.

For the details of WBI INVESTMENTS's stock buys and sells,go to www.gurufocus.com/guru/wbi+investments/current-portfolio/portfolio

These are the top 5 holdings of WBI INVESTMENTS

  1. Xtrackers USD High Yield Corporate Bond ETF (HYLB) - 1,343,854 shares, 14.27% of the total portfolio. Shares reduced by 8.95%
  2. iShares Broad USD High Yield Corporate Bond ETF (USHY) - 1,594,883 shares, 13.96% of the total portfolio. Shares reduced by 8.82%
  3. VanEck Vectors Fallen Angel High Yield Bond ETF (ANGL) - 746,231 shares, 5.06% of the total portfolio. Shares reduced by 9.77%
  4. AbbVie Inc (ABBV) - 105,406 shares, 2.42% of the total portfolio. Shares added by 436.72%
  5. Microsoft Corp (MSFT) - 36,308 shares, 1.82% of the total portfolio. Shares added by 39.20%

New Purchase: Raymond James Financial Inc (RJF)

Wbi Investments initiated holding in Raymond James Financial Inc. The purchase prices were between $94.03 and $123.59, with an estimated average price of $111.82. The stock is now traded at around $129.360000. The impact to a portfolio due to this purchase was 1.67%. The holding were 63,996 shares as of 2021-03-31.

New Purchase: Best Buy Co Inc (BBY)

Wbi Investments initiated holding in Best Buy Co Inc. The purchase prices were between $98.24 and $120.96, with an estimated average price of $112.12. The stock is now traded at around $116.150000. The impact to a portfolio due to this purchase was 1.36%. The holding were 55,818 shares as of 2021-03-31.

New Purchase: Diamondback Energy Inc (FANG)

Wbi Investments initiated holding in Diamondback Energy Inc. The purchase prices were between $48.94 and $85.27, with an estimated average price of $68.5. The stock is now traded at around $79.480000. The impact to a portfolio due to this purchase was 1.17%. The holding were 74,701 shares as of 2021-03-31.

New Purchase: Cummins Inc (CMI)

Wbi Investments initiated holding in Cummins Inc. The purchase prices were between $221.37 and $275.99, with an estimated average price of $249.73. The stock is now traded at around $257.670000. The impact to a portfolio due to this purchase was 1.07%. The holding were 19,346 shares as of 2021-03-31.

New Purchase: Gilead Sciences Inc (GILD)

Wbi Investments initiated holding in Gilead Sciences Inc. The purchase prices were between $60 and $68.46, with an estimated average price of $64.52. The stock is now traded at around $67.450000. The impact to a portfolio due to this purchase was 1.02%. The holding were 74,450 shares as of 2021-03-31.

New Purchase: Ameriprise Financial Inc (AMP)

Wbi Investments initiated holding in Ameriprise Financial Inc. The purchase prices were between $187.01 and $232.8, with an estimated average price of $216.26. The stock is now traded at around $250.840000. The impact to a portfolio due to this purchase was 1.01%. The holding were 20,497 shares as of 2021-03-31.

Added: AbbVie Inc (ABBV)

Wbi Investments added to a holding in AbbVie Inc by 436.72%. The purchase prices were between $102.3 and $112.62, with an estimated average price of $106.92. The stock is now traded at around $114.960000. The impact to a portfolio due to this purchase was 1.97%. The holding were 105,406 shares as of 2021-03-31.

Added: A.O. Smith Corp (AOS)

Wbi Investments added to a holding in A.O. Smith Corp by 719.43%. The purchase prices were between $53.19 and $69.49, with an estimated average price of $60.8. The stock is now traded at around $68.490000. The impact to a portfolio due to this purchase was 1.02%. The holding were 80,648 shares as of 2021-03-31.

Added: Target Corp (TGT)

Wbi Investments added to a holding in Target Corp by 100.52%. The purchase prices were between $169.82 and $200.95, with an estimated average price of $187.23. The stock is now traded at around $202.960000. The impact to a portfolio due to this purchase was 0.88%. The holding were 41,563 shares as of 2021-03-31.

Added: Accenture PLC (ACN)

Wbi Investments added to a holding in Accenture PLC by 156.74%. The purchase prices were between $241.92 and $280.77, with an estimated average price of $258.46. The stock is now traded at around $279.390000. The impact to a portfolio due to this purchase was 0.73%. The holding were 20,352 shares as of 2021-03-31.

Added: Broadridge Financial Solutions Inc (BR)

Wbi Investments added to a holding in Broadridge Financial Solutions Inc by 96.33%. The purchase prices were between $139.17 and $157.31, with an estimated average price of $147.67. The stock is now traded at around $159.020000. The impact to a portfolio due to this purchase was 0.7%. The holding were 43,877 shares as of 2021-03-31.

Added: Principal Financial Group Inc (PFG)

Wbi Investments added to a holding in Principal Financial Group Inc by 505.81%. The purchase prices were between $48.31 and $61.55, with an estimated average price of $55.71. The stock is now traded at around $63.420000. The impact to a portfolio due to this purchase was 0.69%. The holding were 65,324 shares as of 2021-03-31.

Sold Out: AstraZeneca PLC (AZN)

Wbi Investments sold out a holding in AstraZeneca PLC. The sale prices were between $47.16 and $54.44, with an estimated average price of $50.29.

Sold Out: Novavax Inc (NVAX)

Wbi Investments sold out a holding in Novavax Inc. The sale prices were between $112.98 and $319.93, with an estimated average price of $200.73.

Sold Out: Bank of America Corp (BAC)

Wbi Investments sold out a holding in Bank of America Corp. The sale prices were between $29.65 and $38.99, with an estimated average price of $34.49.

Sold Out: CRISPR Therapeutics AG (CRSP)

Wbi Investments sold out a holding in CRISPR Therapeutics AG. The sale prices were between $110.72 and $210.04, with an estimated average price of $151.16.

Sold Out: Sherwin-Williams Co (SHW)

Wbi Investments sold out a holding in Sherwin-Williams Co. The sale prices were between $219.85 and $253.01, with an estimated average price of $238.3.

Sold Out: Apple Inc (AAPL)

Wbi Investments sold out a holding in Apple Inc. The sale prices were between $116.36 and $143.16, with an estimated average price of $128.47.

Here is the complete portfolio of WBI INVESTMENTS. Also check out:

1. WBI INVESTMENTS's Undervalued Stocks
2. WBI INVESTMENTS's Top Growth Companies, and
3. WBI INVESTMENTS's High Yield stocks
4. Stocks that WBI INVESTMENTS keeps buying



Source link